Navigable Brain Biopsy Cannula Set
Neurological Stereotaxic Instrument. 510(k) K140705, from Izi Medical Products (Owings Mills, MD). Product code HAW, class 2.
As of Nov 20, 2026, K140705 is an FDA 510(k) held by Izi Medical Products, substantially equivalent on Dec 5, 2014 after 259 days, with no recalls tied to it in FDA's recall database.
- Review time: 259 days
- Recalls: 0
The BL Navigated Biopsy Needle is indicated for stereotactic biopsy of cranial tissue using BrainLab AG’s VectorVision navigation system. The Navigated Biopsy Needle is a pre-sterilized, single-use, side-cutting needle where the cutting action is achieved by rotation of an inner cannula within an outer cannula.
- Modification To: Vectorvision Frameless Biopsy SystemK012564 · Brainlab AG · Sep 6, 2001
- Snt Disposable Biopsy NeedleK971247 · Surgical Navigation Technologies, Inc. · Jun 16, 1997
- Stereotactic Ultralight System SUSyK261157 · inomed Medizintechnik GmbH · Nov 6, 2026
- StealthStation™ S8 Cranial v2.3.0K262716 · Medtronic Navigation · Nov 6, 2026
- NeuroAlignK261997 · Medivis, Inc. · Oct 26, 2026
- Disposable Reflective Marker Spheres (AM-BK115S, AM-BL130S)K262214 · Guangzhou Aimooe Technology Co., Ltd. · Oct 15, 2026
- Geniant Cranial (Navigated Neurosurgical Positioning Robot)K253856 · Koh Young Technology, Inc. · Sep 10, 2026
- Leksell® Vantage Stereotactic SystemK261932 · Elekta Solutions AB · Aug 5, 2026
- Zeta Navigation SystemK253663 · Zeta Surgical, Inc. · May 1, 2026
- Stealth AXiS Cranial clinical applicationK253379 · Medtronic Navigation, Inc. · Mar 26, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 21, 2014
- Review panel
- Neurology
- Regulation
- 21 CFR 882.4560
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files